Last reviewed · How we verify

NCT07164638

Lung Ultrasound Versus Inferior Vena Cava Collapsibility Index for Early Prediction of Volume Overload During Transurethral Resection of Prostate

ENROLLING BY INVITATION NA Last updated 10 September 2025
What this trial tests

NA trial testing lung ultrasound (LUS) in Lung Ultrasound Score in 60 participants. Enrolling by invitation.

Timeline
30 October 2024
Primary endpoint
30 October 2025
30 October 2025

Quick facts

Lead sponsorTanta University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationna
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment60
Start date30 October 2024
Primary completion30 October 2025
Estimated completion30 October 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Eligibility, male only, with Lung Ultrasound Score or Transurethral Resection (TUR) Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare between accuracy of lung US and IVC CI for early prediction of volume overload during TURP. Primary outcome: The incidence of volume overload during transurethral resection of prostate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of lung ultrasound (LUS)

Trials testing the same drug.

Other recruiting trials for Lung Ultrasound Score

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07164638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing